About
Dr. Rebbaa received his PhD from Claude Bernard University, Lyon, France. He held research and faculty positions at Northwestern University, the University of Pittsburgh, and Columbia University. Over the course of his carrier, his research encompassed target and drug discovery and development in the fields of cancer, stem cells and aging. He served as a Principal Investigator on multiple grants, published over 40 manuscripts and reviewed manuscripts for several high impact scientific journals. In his recent role at Ichor Therapeutics, he oversaw the discovery and preclinical testing of small molecule senolytics and biomarkers of aging. Building on this knowledge and experience, Dr. Rebbaa is conducting innovative projects at the SENS Research Foundation. He will be overseeing this proposed anti-senescence screening project that holds promise for the discovery of translatable anti-aging therapies.
Joined
April 2023
